12:39 AM ET
Earnings Call
▶ Call
Travere Therapeutics Earnings Call: Key Takeaways
Travere achieved record quarterly revenue of $220.2 million, driven by Filspari's expansion into FSGS, though management faces a CEO transition and increased competition in the IgA nephropathy market.
- Call
- Nov 2, 2026, 4:30 PM ET